The Saudi Arabia blood glucose monitoring devices market size was estimated at USD 96.63 million in 2025 and is projected to be worth around USD 228.76 million by 2035, growing at a CAGR of 9% from 2026 to 2035. The growing prevalence of diabetes and technological advancements are driving the market.

Saudi Arabia Blood Glucose Monitoring Devices Market Statical Scope

Blood glucose monitoring (BGM) devices are instrumental in assisting individuals with diabetes by enabling both patients and healthcare professionals to identify fluctuations in blood glucose levels. This functionality allows for timely adjustments to treatment plans, serving as a safeguard by quickly confirming episodes of hypoglycemia or hyperglycemia and thereby ensuring patient well-being.

The increasing incidence of diabetes in Saudi Arabia significantly drives the demand for blood glucose monitoring devices. Vision 2030 is transforming the diabetes care landscape in Saudi Arabia by prioritizing preventive healthcare and digital health solutions for chronic disease management. Strategic governmental initiatives are fostering the adoption of advanced glucose monitoring technologies within both urban and rural healthcare facilities, thereby enhancing access to digital diabetes management tools.

Saudi Arabia Blood Glucose Monitoring Devices Market Share, By Product, 2025, (%)

• Self-monitoring Devices - self-monitoring devices are widely used for routine blood glucose tracking due to affordability and ease of use, with a 68% share, establishing self-monitoring devices as the dominating product segment.
• Continuous glucose monitoring devices- Rising demand for real-time monitoring and advanced diabetes management, with a 32% share, is driving rapid growth in this segment.

Saudi Arabia Blood Glucose Monitoring Devices Market Share, By End Use, 2025, (%)

• Hospitals - High patient inflow and access to advanced monitoring healthcare structure, with a 42% share, establish hospitals as the dominating end-use segment.
• Homecare - growing preference for at-home disease management and convenience, with a 38% share, is driving the fastest growth in this segment.
• Diagnostic centers - Used for periodic testing and accurate diagnosis, with a 20% share, is boosting the segment growth.

Top Companies in the Saudi Arabia Blood Glucose Monitoring Devices Market

• Medtronic plc
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• Bayer AG
• Lifescan, Inc.
• Dexcom Inc.
• Insulet Corporation
• Sanofi
• Novo Nordisk A/S

Segments Covered in the Report

By Product

• Self-monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
• Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitter & Receiver
  • Insulin Pumps

By End-use

• Hospitals
• Homecare
• Diagnostic Centers